The tumor apparently arises from spindle-shaped pericytes that lie at the basement membrane of capillary blood vessels. Although half of the patients are asymptomatic, the others’ signs and symptoms are protean, such as dysphagia, Pancoast syndrome like features and occurrence of a spontaneous hemothorax.
Herein, a completely resected case of primary mediastinal hemangiopericytoma is presented with its clinic, pathologic and radiographic features.
The magnetic resonance imaging (MRI) showed a high-intensity mass not invading the aorta in the T1 and T2-weighted images (WIs) (Fig. 1). There was no evidence suggesting another primary tumor or metastasis, and a surgical management was suggested.
The patient underwent a left-sided thoracotomy. During the thoracotomy, a 4-cm solid mass was found originating from the mediastinum, proximally of the left main pulmonary artery, but without a bronchial attachment or any significant arterial supply. There was an involvement of the surrounding lung parenchyma. Despite the persistent bleeding during the dissection, the tumor was resected. The frozen section of the lesion suggested a thymoma, a benign spindle cell tumor or another low grade soft tissue sarcoma; and therefore, there was no need for any extended resection.
The tumor mainly consisted of fleshy fragments. They were not circumscribed and did not show any extensions into the lung. Histologically; there was a cellular mesenchymal tumor composed of round or fusiform cells demonstrating focal cellular pleomorphism. It was rich in thin-walled branching vessels forming a staghorn vascular pattern. There was no necrosis. The mitotic activity was approximately three per 10-high-power microscopic fields and the Ki-67 immunoreactivity was around 5%. The tumor was reported to be a “hemangiopericytoma having low malignant potential” (Fig. 2).
The postoperative course was uneventful and patient was discharged on the sixth postoperative day. Two weeks after the operation, a positron emission tomography (PET) scan was performed to rule out the possibility of an incomplete resection and distant metastases. There was no evidence of any of these pathologies. A postoperative chemo-radiotherapy was not recommended. Today, 14 months after the operation, the patient is well and there is no evidence of any recurrence or metastasis.
Hemangiopericytoma was initially described by Stout and Murray.[1] The skin, musculoskeletal system and retroperitoneal areas are most commonly affected. Only a few cases of tumor originating from the mediastinum have previously been reported. The diagnosis of extra-pulmonary tumor is difficult. Most of the patients are asymptomatic. A non-calcified solitary mass with a smooth margin is discovered on the chest-X-ray. Because this is a vascular tumor usually demonstrating hypervascularity, MRI or angiography are more effective diagnostic tools rather than a CT scan. In our case, the angiography was normal and the MRI demonstrated a high intensity on T1 and T2-WIs. Kusumoto et al.[2] have reported that the MRI shows a characteristic high signals on T2-WIs and this feature can be useful to detect an early recurrence or metastatic lesions.
The most important fields of use of the PET include evaluating solitary pulmonary nodules and the mediastinal staging of lung cancer. Its mechanism depends on the increased usage of glucose for the increased mitotic activity in cells like the cancer cells. Although there is no information about using PET for hemangiopericytoma in the literature, we chose to use it in our case because the mitotic activity rate of the lesion was relatively higher than the other benign lesions.
The histological differential diagnosis of hemangiopericytoma includes many mesenchymal tumors, such as the solitary fibrous tumor and the synovial sarcoma.[3] The diagnosis can be difficult in the preoperative stage. A frozen section may not be reliable.[4] In our case, the frozen section of the lesion demonstrated a thymoma, benign spindle cell tumor or another low-grade soft tissue sarcoma.
The histopathological examination plays a very important role in the diagnosis of the tumors with four or more mitoses per 10 high-power microscopic fields, prominent cellular pleomorphism, increased cellularity and areas of hemorrhage and necrosis are usually malignant. Immunohistochemically, hemangiopericytomas are known to be stained for vimentin type 4 collagen and they were not stained for type 8-related antigen, S-100 protein, neuron specific enolase, carcinoembryonic antigen, desmins, laminin and cytokeratins.
Surgical resection is the first choice of treatment.[3] Hansen et al.[4] stated that it was necessary to consider all hemangiopericytomas as malignant and perform extended surgery, however the criteria for determining the area of resection has not been established yet. Chemotherapy, radiotherapy or both have been recommended, however, it is generally considered to be almost ineffective.[3] On the other hand, combination therapy or single therapy with Adriamycin was reported to be effective against metastases.[5] In order to allow a safe and complete removal of the lesion; Jalal and Jeyasingham[6] have suggested that preoperative radiotherapy to large hemangiopericytomas located on the chest wall, significantly reduced their vascularity. Morandi et al.[7] have suggested preoperative percutaneous embolization of hypervascular mediastinal tumors.
The five-year survival rate of patients with hemangiopericytomas originating in any organ has been reported to be approximately 85%, whereas the survival rate of patients with a tumor of pulmonary or mediastinal origin is comparatively low.[4]
In conclusion, hemangiopericytoma, a vascular, slow-growing tumor, is rarely encountered in the mediastinum. A radical surgical excision is necessary for the treatment, because other treatment modalities are ineffective. Based on our experiences from this case, we want to emphasize that the characteristic high signal on T2-WIs in the preoperative MRI and a massive intraoperative bleeding. Local or distant recurrence is commonly seen and a long-term follow-up is required.
1) Stout AP, Murray MR. Hemangiopericytoma: a vascular
tumor featuring Zimmermann’s pericytes. Ann Surg 1942;
116:26-33.
2) Kusumoto S, Nakamura R, Mizoguchi N, Ono S, Watanabe
K. Primary intrathoracic extrapulmonary hemangiopericytoma.
CT and MR findings. Clin Imaging 1997;21:51-3.
3) Espat NJ, Lewis JJ, Leung D, Woodruff JM, Antonescu CR,
Shia J, et al. Conventional hemangiopericytoma: modern
analysis of outcome. Cancer 2002;95:1746-51.
4) Hansen CP, Francis D, Bertelsen S. Primary hemangiopericytoma
of the lung. Case report. Scand J Thorac Cardiovasc
Surg 1990;24:89-92.
5) Rusch VW, Shuman WP, Schmidt R, Laramore GE. Massive
pulmonary hemangiopericytoma. An innovative approach to
evaluation and treatment. Cancer 1989;64:1928-36.